Insights

All Biomarkers in Biotechnology Biotech Investment Clinical Laboratory Consulting Company Histories Lab Compliance & Validation Marketing Technology

Marketing

4 min read

Losing Touch: Why Big Companies Lose Focus on Their Customers

When startups are just starting out, their main goal is to attract customers and create a unique experience to stand out in the competition.
Young companies build flexible service systems, respond to requests and do everything possible to make customers feel heard.
As businesses expand and achieve greater success, they often seem to drift away from the personal connection that forms the essence of quality customer service.
This drift often explains why big companies lose customers despite their massive scale and success.
What causes this evolution?

Amazon: The Path from Startup to Giant

The example of Amazon shows this transformation. Founder Jeff Bezos repeatedly emphasized the importance of feedback,
personally reading customer complaints and implementing changes. Today, Amazon is a multi-billion dollar giant,
and the company’s customer service, to put it mildly, is far from perfect.

Try contacting Amazon technical support – it can turn into a real quest. Automatic response systems that often give irrelevant answers, the inability to talk to a person, redirects in endless chatbots. There is a feeling that customer service is no longer a company priority. This may be due to the belief that a huge customer base (millions of users) provides stable income, even if some customers leave. For example, the loss of 100-200 thousand customers with a base of 10 million is barely noticeable for financial indicators. But is this correct from the point of view of long-term strategy?

The Stagnation Phase: Why Do Companies Stop?

When a startup turns into a corporation, priorities shift. Instead of investing in service quality, the focus goes to scaling and cost optimization. This often leads to outsourcing technical support to countries with cheap labor, where the quality of service is noticeably reduced.

Another problem is managing a huge number of customers. Company leaders, once satiated with success, can go into the “autopilot” phase, believing that the business is already working like a well-oiled machine. But this method weakens customer trust and can cause serious harm to a company’s reputation.

Solution: Artificial Intelligence as a New Standard

One way to solve the problem of large-scale and high-quality service is to use artificial intelligence (AI). Despite the fears associated with the introduction of AI, it can be a salvation. Modern algorithms are capable of not only automating routine processes, but also providing a more personalized and accurate approach to each client.

For example, AI can analyze customer requests, predict their needs and provide answers that are relevant and timely. This will significantly reduce the burden on human resources and avoid problems associated with outsourcing.

Why You Shouldn’t Be Afraid of AI

Fears that AI will replace people are actually groundless. Yes, some professions, such as a technical support operator, may become a thing of the past. But this will open up new opportunities for people. Freed from routine work, humanity will be able to direct its efforts to education and development.

History has repeatedly shown that technological revolutions stimulate the development of society. The transition from horses to cars, from manual labor to automated production – each time it led to the emergence of new professions and skills. Artificial intelligence is not a threat, but an opportunity to raise the level of education and develop human potential.

by Biotech Insight Solutions

Biotech Investment

3 min read

How to Choose a Biotech Company to Invest In: Key Recommendations

Investing in biotech can bring high rewards—but also significant risks. The biotech sector is complex, and a company’s success depends on multiple factors, including scientific research, clinical trial results, management, and financial support. Here are essential tips to help you make an informed decision before investing in a biotech company.

1. Evaluate the Scientific Foundation and Technology Platform

Start by examining its scientific foundation and technology platform. Look for innovations and the scientific achievements that back them. Patents or intellectual property protection are vital indicators that the company’s developments are well-protected.

2. Review Clinical Trial Results

Clinical trials are often a key indicator of a biotech company’s progress. Check if the company has a clear strategy for advancing through each phase of clinical trials. The closer they are to completing these stages, the less risk there is for investors. Dive into trial results, methodologies, and sample sizes for a thorough understanding.

3. Assess the Management Team

A capable and experienced team can make a significant difference in the company’s success. Review the backgrounds of the leadership and scientific advisors, and look for proven experience in biotechnology and past successes. A strong, reliable team often increases a company’s chance of successful growth and development.

4. Analyze Financial Stability

Financial health is a cornerstone of any viable investment. Look into the company’s revenue, expenses, debts, and funding sources. Ensuring that they have adequate resources to support ongoing research and clinical trials is crucial.

5. Assess Market Potential and Competition

Investigate the market that the company serves and evaluate its potential customer base. Look at competitors and their advancements to gauge how unique and in-demand the company’s technology is. A company with strong competitive advantages is better positioned for long-term success.

6. Take a Closer Look at the Company’s Reputation and Its Partners

When considering a biotech investment, don’t overlook the company’s reputation and the quality of its partnerships. Positive reviews, solid partnerships, and affiliations with respected institutions can be good indicators of a company’s stability and reliability. These connections often speak volumes about the company’s standing in the industry, so take the time to dig a little deeper.

7. Get Expert Help for Thorough Due Diligence

Biotech investments aren’t simple, especially with the involvement of scientific data and potential risks. If interpreting this information feels daunting, it’s well worth consulting with experts who specialize in due diligence. Having a professional guide can save you from costly mistakes and help you zero in on projects with solid, trustworthy foundations.

Final Thoughts

Biotech investing can be incredibly rewarding. On the other hand, it’s also full of complexities. Taking the time to research is essential for finding the right opportunities. When needed, bringing in expert advice can make the process even more effective. In this industry, solid and reliable companies are the ones that truly show their worth over time. Big promises might sound appealing, but they often fall short. By focusing on companies with a strong foundation, you’re setting yourself up for steady, long-term success.

by Biotech Insight Solutions

Biotech Investment

3 min read

Why Scientific Reproducibility Matters for Biotechnology Investment Risks

In today’s biotech world, science has become incredibly complex and multi-layered. Published results are often taken as gospel, but the reality is that you can’t always rely on the conclusions of papers and studies. Recent research shows alarming statistics: many scientific studies cannot be reproduced. In 2016, a study published in Nature found that most scientists had difficulty reproducing the results of their own and other people’s experiments. In 2024, a study on the topic confirmed that problems with reproducibility persist in the biomedical field and affect the credibility of research.

This is especially important for biotech investors. Investing in a project with an unstable scientific base carries enormous risks. In an environment where many research results are difficult or impossible to reproduce, rigorous scientific verification through due diligence is essential for informed investment decisions.

The Role of Expertise in a World of Complex Data

Preparing to invest in biotech requires a deep understanding not only of the specific science, but also of the reliability of the research methodology. Numerous factors can lead to a research result being non-reproducible: pressure to publish, limited resources to validate experiments, statistical errors, or even bias. In such situations, it is important to have a trusted expert who will conduct a detailed analysis of the data to identify the potential and weaknesses of each project.

Professional analysis helps to identify both the real prospects of the project and possible pitfalls. Such support, like a reliable guide, points the investor to projects that have solid scientific evidence and prospects, and helps to avoid those that do not have a reliable basis.

Support in Making Investment Decisions

In order to invest in biotechnology successfully, one must have faith in its dependability in addition to an interest in science. Careful scientific research is necessary to obtain this level of assurance in a setting where many studies are still non-reproducible. Expert due diligence enables businesses to see past the statistics and distinguish between projects that are merely false prospects and those that have potential.

Having a trustworthy partner who can decipher complicated scientific data aids investors in making wise decisions, conserving money, and preventing losses. Relying on reproducible and effective scientific evidence is crucial when investing in biotechnology, which is a long-term endeavour.

References:

Cobey KD, Ebrahimzadeh S, Page MJ, Thibault RT, Nguyen PY, Abu-Dalfa F, Moher D. Biomedical researchers’ perspectives on the reproducibility of research. PLoS Biol. 2024 Nov 5;22(11):e3002870. doi: 10.1371/journal.pbio.3002870. PMID: 39499707; PMCID: PMC11537370.

Baker, M. 1,500 scientists lift the lid on reproducibility. Nature 533, 452–454 (2016). https://doi.org/10.1038/533452a

by Biotech Insight Solutions

Technology

3 min read

How DNA Could Replace Hard Drives

Today, hard drives and flash drives are the primary means of storing data. However, in terms of power consumption, longevity, and storage density, these technologies are limited. This, however, could change in the near future. Researchers have focused on DNA as an alternative to silicon-based media. DNA offers a greater density of information storage and is also more tolerant to environmental changes. Technologies that use DNA for data storage have already shown promise, but conventional approaches require DNA synthesis, which increases costs and slows down recording speeds.

The study published in Nature presents a new approach to storing data on DNA. Researchers from the USA and China developed a method that records data without the need for synthesis, using existing nucleic acids and epigenetic modifications as bits of information. This new method combines parallel recording of epigenetic bits (epi-bits) with DNA self-assembly and enzymatic methylation, where modifications such as cytosine methylation act as information bits. These modifications are applied to pre-prepared DNA templates, enabling the creation of a molecular “typewriter.” This makes it a promising solution for mass data storage.

The researchers created a system that allows such marks to be “stamped” onto DNA in large quantities. For example, using this technology, they recorded more than 275,000 bits of data — about 34,000 words of text, with 350 bits per reaction. And this is by using just five DNA templates and a set of 700 “stamps” (or epigenetic bits). The data is read using nanopore sequencing technology, which functions similarly to scanning a book’s pages to determine the precise location and meaning of the markings. Special algorithms have been developed to distinguish up to 240 modification patterns in a single read. This allows for swift and accurate reconstruction of the stored data. An important achievement is that the system can be used by people without specialized laboratory experience, emphasizing the potential for widespread use.

Imagine that you have books with blank pages on your bookcase. You “print” the needed information rapidly by using special stamps with letters and symbols, rather than writing the text by hand on each page. The marks on the DNA serve as letter stamps in this investigation, while the DNA itself serves as a bookshelf. These markers, which are epigenetic changes like methylation, function as “bits” of information, or 1s and 0s.

This technology provides a novel method of data storage that benefits from parallelism, stability, and scalability. Not only does this make data collection and interpretation more efficient, but it can also be used by those without specialized laboratory equipment. This opens up the possibility of wider use and possible incorporation into everyday activities.

Reference:
Zhang, C., Wu, R., Sun, F. et al. Parallel molecular data storage by printing epigenetic bits on DNA. Nature 634, 824–832 (2024). https://doi.org/10.1038/s41586-024-08040-5

by Biotech Insight Solutions